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A B S T R A C T
This work aims to evaluate the possible use of a poly(sodium methacrylate, methyl methacrylate) (NaPMM⁠2)
plasticized by PEG400 in design orodispersible films (ODF). Placebo ODF prepared by solvent casting were in-
tended to study the impact of the polymer/plasticizer ratio and residual moisture on disintegration time, stick-
iness and mechanical properties. The drug loading capacity was assessed using ketoprofen and paracetamol.
Placebo ODF containing PEG400 in the 10–30% w/w range and 10–15% of residual moisture content were
easy-to-handle, packed without failures and completely dissolved within 30s.
NaPMM⁠2/PEG400 in 80/20 ratio allowed up to 70% of paracetamol loading, which appeared as the largest
value described in literature. This ODF showed good mechanical properties and disintegration time. The same
formulation loaded with 25% or 50% ketoprofen (pK⁠a=4.45) swelled without disintegrating, because of a par-
tial protonation of NaPPM⁠2, as verified by ATR-FTIR spectroscopy. However, the addition of 5% surfactants al-
lowed the formulation of ODF containing 25% ketoprofen that disintegrated within one minute and guaranteed
the complete drug dissolution within 5min. All the presented data, discussed in the framework of information
available on such copolymer, highlighted its versatility in the design of orodispersible dosage forms.
1. Introduction
Nowadays, serious attempts are being made to develop medicines,
formulations, and dosage forms that are adapted to the specific needs
of patients who stand at the edge of the entire population, namely pe-
diatric, elderly and dysphagic patients (Borges et al., 2015; Dixit and
Puthli, 2009). The European Medicines Agency stepped into the topic by
emitting a guideline on the pharmaceutical development of medicines
for pediatric use (EMA/CHMP/QWP/805880/2012 Rev. 2) and a rec-
ommendation on the need of a reflection paper concerning the quality
aspects of medicines for elderly patients (EMA/165974/2013). Indeed,
the most critical points are dosage accuracy and swallowing difficulties
in pediatric and elderly patients, respectively.
Orodispersible films (ODF) have been proposed to overcome phys-
iologic or psychologic impairments in swallowing tablets and capsules
or the fear of chocking and to extend the patentability of these dosage
forms (Cilurzo et al., 2017). Moreover, very recent pharmacokinetic
studies reported the bioequivalence of ondansetron ODF with orally dis-
integrating tablets under both fasted and fed conditions (Dadey, 2015),
indicating the suitability of ODF as an alternative to orodispersible
tablets.
ODF are usually constituted of plasticized water-soluble macromole-
cules that are predominantly laminated by solvent casting and sealed in
moisture-protecting packages. The drug dose is determined by the thick-
ness and size of the dried film. Thus, different dose strengths may be
obtained from the same formulation cut in different shapes.
Over the last decade, several film-forming polymers have been pro-
posed to design ODF (Borges et al., 2015). However, each proposed
material exhibits peculiar difficulties related to foaming during solvent
evaporation, flaking during slitting, cracking during cutting or sticking
to the packaging material or patients' fingers during handling. There-
fore, the addition of auxiliary excipients is often required, thus de-
creasing the already limited formulation space of such dosage form.
As an example, the mechanical properties of maltodextrin films can
be compromised by the loaded drug and/or the taste masking agents
(Cilurzo et al., 2011) so that other excipients could be required to rein-
force the polymeric film (Selmin et al., 2015; Franceschini et al., 2016).
Hence, there is no doubt that the most critical point is the choice of the
film-forming polymer and efforts should be invested to assure the ap-
propriate mechanical resistance.
Poly(sodium methacrylate, methyl methacrylate)s, NaPMMs, and
poly(potassium methacrylate, methyl methacrylate)s, KPMMs, have
been proposed to design drug delivery systems intended for buccal
administration of ac
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tive ingredients (; ). These materials are obtained by neutralizing with
alkali two grades of pharmaceutical approved polymers having 1:1 (Eu-
dragit® L, HPMM⁠1) or 1:2 (Eudragit® S, HPMM⁠2) monomer ratio. Inde-
pendently of the monomer ratio, NaPMMs and KPMMs showed promis-
ing properties to design ODF exhibiting the substantial characteristics
required, namely very fast dissolution rate and a low swelling pro-
file with respect to low molecular weight HPMC (Cilurzo et al., 2003).
Among these four polymeric materials, NaPMM⁠2 appeared the most suit-
able for the design of buccal dosage forms thanks to its taste.
In the light of above considerations, the aim of the present study
was to evaluate the possible use of NaPMM⁠2 as film-forming polymer to
design ODF. Taking into consideration that mechanical properties and
drug loading are critical attributes of an ODF, the work was organized
in two steps. Preliminarily, placebo ODF made of NaPMM⁠2 plasticized
by PEG400 were prepared by a solvent casting technique focusing the
attention on the ratio and process variables which determine both film
flexibility and tenacity. Then, the formulation having the most suitable
tensile properties for manufacturing and handling was loaded with two
model drugs. Paracetamol was used to determine the maximum loading
capacity of the ODF in the attempt to obtain a final dosage form suitable
for pediatrics; ketoprofen was selected as an acidic drug model, which
can alter the ratio between the sodium carboxylate and carboxylic acid
residues of NaPMM⁠2 and, therefore, affect the disintegration time of the
ODF. Both disintegration and dissolution tests were carried out in water
and artificial saliva to determine the impact of pH and cations on the
in vitro performances of the ODF. Indeed, since NaPMM⁠2 is a pH-depen-
dent copolymer sensitive to the presence of bivalent cations (Cilurzo et
al., 2005; Cilurzo et al., 2010a, 2010b), the variation of microenviron-
mental composition can cause the formation of physical cross-linking af-
fecting the polymer dissolution rate.
2. Material and Methods
2.1. Materials
Poly(sodium methacrylate, methyl methacrylate) (NaPMM⁠2, molar
proportions of the monomer units 1:2, molecular weight 135,000Da)
was prepared as previously described (Cilurzo et al., 2003). Briefly, 15%
w/w Eudragit®S100 (Evonik Industries, G) aqueous suspension was sali-
fied by adding sodium hydroxide pellets. The required amount of NaOH
(0.12g/g of Eudragit® S100) was calculated after titration on the basis
of the Ph. Eur. method. Ketoprofen was kindly provided by MIAT S.p.A.
(I).
Paracetamol (Farmalabor, I); PEG400 and Tween®80 (Carlo Erba
Reagenti, I); Span®80 (Croda, E).
2.2. Preparation of Films
To prepare the casting solution, PEG400 was added to a 10% w/w
NaPMM⁠2 solution under magnetic stirring in order to obtain the
NaPMM⁠2/plasticizer ratios from 90/10 to 40/60% w/w (Table 1). The
active ingredients were added to the slurry to obtain the concentration
reported in Table 2. After a rest period to remove bubbles, the disper-
sion was cast at the rate 1m/min over a silicone release liner and a coat-
ing thickness was set to obtain ~100μm films (Mathis LTE-S(M), CH).
Films were, then, cut into the shape and size required for testing, packed
in individual airtight seal packs using a triple layer film, and stored at
25±1°C until use.
2.3. Film Flexibility
The film flexibility was determined as follow: a 2×3 cm sample was
bent for ten times over an 8-mm mandrel and examined for cracks over
the bending area. The film was considered flexible if no cracks were vis-
ible at a 5× magnification using an optical microscopy (Nikon, I).
2.4. Loss on Drying
The loss on drying (LOD) in films was determined gravimetrically by
using a thermobalance (Gilbertini, I). Film samples were kept at 105°C
until constant weight was reached.
2.5. Thickness
Film thickness was measured by using a MI 1000 (ChemInstruments,
USA). The accuracy of the instrument was 2.5μm±0.5%. Before sam-
ples cutting, the film was placed between the anvil and the presser foot
of the micrometer. Film thickness was measured in ten different posi-
tions and the result was expressed as the mean value.
2.6. Thumb Tack Test
The ODF stickiness at different plasticizer contents was evaluated
by the thumb tack test (Minghetti et al., 2004). Briefly, the thumb was
pressed lightly on a film sample for a short time and, then, quickly with-
drawn. By varying the pressure and time of contact and noting the dif-
ficulty of pulling the thumb from the adhesive, it is possible to perceive
how easily, quickly and strongly the adhesive can form a bond with
the thumb. All the tests were simultaneously performed and blind. The
stickiness of the ODF was expressed by the following score system: very
stick, stick and no stick.
Table 1
Effect of concentration of PEG400 and water (LOD, %) on film mechanical properties. Results are expressed as the mean of five measurements±standard deviation. Tensile pattern is














test Y (MPa) σ⁠max (MPa) ε (%) TEB (MPa)
Tensile
pattern
1a 90 10 35±2 Y No
stick
0.33±0.17 1.49±0.44 44.2±13.6 0.42±0.07 N
1b 29±1 N No
stick
-⁠b
2a 80 20 31±1 Y No
stick
2.61±0.39 9.04±1.12 31.2±5.2 1.86±0.65 N
2b 25±1 Y No
stick
3.70±0.29 13.46±1.67 32.4±10.7 3.24±1.43 N
2c 19±2 N No
stick
-⁠b
3a 70 30 24±2 Y No
stick
1.32±0.29 4.71±0.35 81.3±6.1 1.97±0.50 T
3b 20±1 Y No
stick
1.94±0.18 8.18±0.43 112.8±29.6 6.84±1.73 T
3c 16±2 N No
stick
-⁠b
4a 60 40 19±1 -⁠a Stick 0.46±0.16 0.46±0.04 510.1±80.1 1.63±0.31 D
4b 16±1 Y No
stick
0.89±0.20 1.09±0.10 235.9±62.8 2.33±0.56 D
4c 10±1 N No
Stick
-⁠b
5 50 50 12±1 -⁠a Very
stick
0.12±0.03 0.54±0.04 958.4±45.4 2.96±0.37 D
a Not performed due to the tackiness of the film.









Technological performance of films obtained NaPMM⁠2 plasticized by 20% PEG400 and loaded with ketoprofen (KP) and paracetamol (PAR). Results are expressed as the mean of five determinations±standard deviation. Tensile pattern is classified according





cm⁠2) Disintegration time t⁠80 (min) Y (MPa) σ⁠max (MPa) ε (%) TEB (MPa) LOD (%)
Tensile
pattern
Water Saliva Water Saliva
6
(PAR 50%)
192±10 12.5 <30s <30s <5 <5 0.34±0.21 1.31±0.43 47±8 0.50±0.14 12±2 T
7
(PAR 70%)
189±8 20.5 <30s <30s <5 <5 1.33±0.19 1.80±0.16 6±1 0.10±0.00 12±2 N
8
(KP 25%)




109±3 4.2 <30s 1min <5 <5 1.24±0.41 2.86±0.62 52±4 1.21±0.25 19±0 T
10
(KP 50%)
173±9 8.3 >15min >15min <5 <5 0.14±0.07 0.61±0.24 197±53 0.88±0.33 18±5 D
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2.7. Probe Tack Test
The probe tack test measures the force required to separate the test
probe tip from a placebo ODF. Experimental conditions were set accord-
ing to an internal standard procedure, using a tensile testing machine
equipped with a 50N load cell (Instron 5965, UK) (Cilurzo et al., 2015).
Measurements were carried out after a 5-min period of exposure to am-
bient conditions. Film samples were cut to obtain 2×2cm specimens.
A strip of double-coated tape (TESA, G), having the same size of the
film specimen, was applied on the flat bottom plate of the tensile test-
ing machine. The specimen was superimposed against the double-coated
tape. The flat stainless steel probe (diameter: 6mm) was placed about
0.05mm above the film. The probe was then lowered onto the film sur-
face and a constant force of 0.05N was applied onto the sample for 5s
and, finally, the probe was removed at the debonding rate of 0.1mm/
s. The absence of film residues on the probe surface (adhesive failure)
was visually determined. The whole force–distance curve (compression
and traction) was recorded. Maximum detachment stress was calculated
by dividing the maximum detachment force by the probe surface and it
was expressed in force per unit area (kPa).
2.8. Tensile Properties
Tensile testing was conducted according to ASTM International Test
Method for Thin Plastic Sheeting (D 882–02) using an Instron 5965 tex-
ture analyzer (Instron, UK), equipped with a 50N load cell. The films
cut into 80×15mm strips, were equilibrated at 25±1°C for 2weeks.
Each test strip was placed longitudinally in the tensile grips on
the texture analyzer. Initial grip separation and crosshead speed were
40mm and 12.5mm/min, respectively. The test was considered con-
cluded at the film break. The following parameters were determined:
Tensile strength (σ) was calculated by dividing the maximum load by
the original cross-sectional area of the specimen and it was expressed in
force per unit area (MPa).
Percent elongation at break (ε) was calculated by dividing the exten-
sion at the moment of rupture of the specimen by the initial gage length
of the specimen and multiplying by 100 according to Eq. (1):
(1)
where L⁠0 is the initial gage length of the specimen and L is the length
at the moment of rupture.
Elastic modulus or Young's modulus (Y) was calculated as the slope of
the linear portion of the stress–strain curve. The result was expressed in
force per unit area (MPa).
Tensile energy to break (TEB) was defined by the arean under the
stress–strain curve. The value is in units of energy.
An average of five measurements was taken for each type of speci-
men.
2.9. Optical Microscopy
The overall morphology and appearance of the ODF were evaluated
by optical microscopy with a stereomicroscope (Nikon, I). Micrographs
were acquired at 20× magnification with a digital camera of 3.1 Mpx
(CCD 3, ToupView, ToupTek, China).
2.10. Thermal Analysis of Drug Loaded ODF
Specimens of the drug as such and of the drug loaded ODF ex-
actly weighted were sealed into 40μL pin holed aluminum standard
pans and subjected to a heating ramp at the rate of 10K/min in a
DSC1 Stare System (Mettler Toledo, CH). The DSC cell was purged
with a dry nitrogen flow of 80mL/
min. The system was calibrated using an indium standard. Data were
treated with Stare System software (Mettler Toledo, CH).
2.11. Attenuated Total Reflection Fourier Transform Infrared Spectroscopy
(ATR-FTIR)
FTIR measurements were performed using a Spectrum™One spec-
trophotometer (PerkinElmer, USA), by placing the samples on a dia-
mond crystal mounted in ATR cell (PerkinElmer, USA). The spectra
recorded at 4cm⁠−1 resolution and 32 scans were collected over the
wavenumber region 4000–650cm⁠−1. The analyses were performed on
raw polymers and ODF.
To assess the homogeneity in composition, FTIR spectra were
recorded at least in two different points of the cast materials.
2.12. Disintegration Test
The disintegration test of films was carried out in water and pH5.7
artificial saliva (Cilurzo et al., 2003) on 3×2 cm sample according to
specifications of the monographs on “Disintegration of tablets and cap-
sules” reported in the Ph. Eur. The test was considered satisfied when
the disintegration time was lower than 3min according to the Ph. Eur.
requirement for orodispersible tablets.
2.13. In Vitro Dissolution Test
The in vitro dissolution test was carried out in a Ph. Eur. paddle dis-
solution apparatus. Samples of drug loaded films were exactly weighed
in order to assure the sink condition. The dissolution medium was
900ml freshly deionized water or pH5.7 artificial saliva (Cilurzo et al.,
2003), maintained at 37±1°C and stirred at 50rpm. Drug concentra-
tions were assayed spectrophotometrically at 233nm and 243nm for ke-
toprofen and paracetamol, respectively (UV–Vis spectrometer, Lambda
25, Perkin Elmer, I). The calibration curves built in both dissolution me-
dia, ranged from 1μg/mL to 70μg/mL (R⁠2>0.99). The results are ex-
pressed as t⁠80, namely the time required to dissolve the 80% of the drug.
3. Results and Discussion
3.1. Placebo Formulations
The placebo formulations were designed by adding different PEG400
amount to NaPPM⁠2 (Table 1) since the films made of 100% w/w
NaPPM⁠2 cracked after being bent 5 times on the mandrel. The poly-
meric dispersions were dried in different operative conditions (i.e., tem-
perature, time and air speed) in order to identify the possible effect of
the drying parameters on the aspect and mechanical properties of the
film. A preliminary screening revealed that drying above 80°C, indepen-
dently of the residue of water, led to a brittle film containing bubbles,
while low temperatures (lower than 60°C), or the lowest air inlet, gave
a film characterized by a ripple surface. In the 60–80°C range, the LOD
content can be easily controlled by drying time and air inlet and, there-
fore, its impact on film features was investigated.
The placebo ODF listed in Table 1 had a uniform thickness of about
100μm and were homogeneously transparent in appearance, easy-to-cut
without cracks or other visible failures.
A critical attribute for an ODF is the stickiness that can affect pa-
tient's handling. In the case of NaPMM⁠2 this property should be carefully
evaluated since this material was proposed for the design of pressure
sensitive adhesives suitable for the development of transdermal patches
(Cilurzo et al., 2014). Thus, the stickiness of the formulations was eval-
uated qualitatively by thumb tack test and quantitatively by probe
tack-test. Both assays evidenced that non-sticking films were obtained
only at PEG400 contents lower than 40% w/w. At highest concentration,
the ODF stickiness was also related to the water content. In particular
the probe tack test evidenced that, at the highest LOD value, the max-
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44±14kPa (Form. 5, Table 1) suggesting the former value as the limit
which would assure that an ODF can be easily handled and removed
from the primary packaging (Borges et al., 2015).
Focusing on film tensile properties, Fig. 1 exemplifies the possible
patterns exhibited by the designed formulations. All films exhibited a
linear region at low strain, which is associated to the reversible defor-
mation. Increasing the strain, the behaviour shifted from elastic to plas-
tic, the curve lost linearity and the deformation became irreversible, un-
til the maximum force (tensile strength, σ) was reached. Afterwards, the
general profiles were outlined on the basis of PEG400 concentrations
and LOD, and three different patterns were identified. Based on the pro-
files and for the sake of completeness, an alphabetic code corresponding
to tensile profile was assigned to each film formulation. First, the max-
imum value was followed by a plateau at a lower value due to a local
reduction of the cross section, namely “tear” or “necking”, which propa-
gated along the length of the sample until rupture. The necking profile
of films can be referred to a pronounced and sharp reduction at a lower
value (code N, Fig. 1) or a slow and smooth decrease of cross section
upon increasing the tensile stress (code T, Fig. 1). Finally, the elonga-
tion at break, which is an index of film ductility, increased up to 200%
(code D, Fig. 1).
From a quantitative point of view, increasing the PEG concentration,
both σ⁠max and Y values dropped down and the ductility prevailed. This
trend, along with the progressive increase of the ε values, is in line with
a plasticization-dominated mechanism, even if it is significantly influ-
enced by the LOD value. Indeed, for formulations with PEG400 content
lower than 40% w/w, the pattern shifted from brittle toward flexible,
according to the LOD values. At the 40% w/w PEG400 concentration,
the increased in the LOD value improved the film ductility and at the
highest value films became sticky (Table 1).
On the basis of the tensile properties, the optimal plasticizer con-
centration ranged from 10 to 30% w/w. Indeed, a certain degree of
elasticity is desired to avoid film brittleness, which would make it im-
possible to roll the film on itself for intermediate storage and trans-
port (i.e., jumbo roll), to cut it into smaller reels of variable width
and finally to punch or cut it to the desired size (Dixit and Puthli,
2009). Indeed, in this plasticizer range, ε values ranged from 30 to
about 100%, that are in the same order of magnitude of ODF pre-
pared with other polymers, such as PVA, HPMC (Tayel et al., 2016),
Carbopol® and hypromellose (Visser et al., 2015; Visser et al., 2017),
already used to manufacture some of marketed dosage forms (Preis
et al., 2014). Moreover, the suitable ε values were associated to σ⁠max
values at least doubled with respect to those reported in literature
for the above-mentioned materials, which ranged from 0.6
to 4MPa. Therefore, it can be assumed that NaPMM⁠2-based films can
bear the tangential stresses applied during manufacturing and packag-
ing procedures. Conversely, at the 40% w/w PEG400 content, the too
high ductility imply that the film easily undergoes elongation when a
tangential stress is applied (Table 1). Therefore, during unrolling and
cutting these films could present problems, which might lead to a varia-
tion of the drug amount per film.
All films disintegrated in <30s satisfying both the FDA and Euro-
pean Pharmacopeia requirements for orodispersible dosage forms.
3.2. Drug Loaded Formulations
One of the main drawback of ODF as dosage forms is the limited
amount of drug that can be loaded in an 8cm⁠2 surface which is the
largest dimension of an ODF perceived as acceptable by patients. The
simple increase in drug loading can affect not only the viscosity of the
casting solution (Visser et al., 2015), but also the mechanical properties
of the film (Cilurzo et al., 2011) and the drug stability (Visser et al.,
2017). Therefore, these dosage forms are generally intended to admin-
ister potent drugs (Borges et al., 2015; Dixit and Puthli, 2009).
In the current work, the feasibility of drug loading was evaluated
on ODF plasticized by 20% w/w PEG400. ODF containing 50% and
70% w/w of paracetamol appeared white and opaque with a very ir-
regular surface (Fig. 2a–b). Such irregularities were more evident at
the highest drug loading, suggesting that the amount of NaPMM⁠2 might
not be enough to uniformly coat the dispersed drug particles. More-
over, the casting process did not cause variation on the drug solid
state since the onset of the melting event of paracetamol loaded in
ODF (T⁠m=164.4±0.4°C) overlapped with that of paracetamol as such
(T⁠m=168.0±0.0). However, the drug resulted partially dissolved in
the ODF matrix as evidenced by the decrease of melting enthalpy
(raw paracetamol ΔH⁠m=174.6±0.1J/g; Form. 6=8.15J/g; Form. 7
ΔH⁠m=92.0±1.2J/g). Table 2 enlists the main characteristics of the
loaded ODF. As expected, maintaining the coating thickness of the cast-
ing solution constant, the final ODF thickness increased. Nevertheless,
the disintegration time did not prove to be influenced and the ODF
promptly released paracetamol, which was completely up to 80% in
<5min both in water or in artificial saliva (Table 2).
The presence of paracetamol did not influence either the film stick-
iness or flexibility, independently of the drug content. On the contrary,
the higher the drug content, the lower the film tenacity (Table 2) which
remained in the range of acceptability.
Fig. 1. The representative stress–strain curves. Tensile behaviour is classified according to an alphabetic code referring to the sharp (N, dashed line, Form. 2b) or slow (T, solid line, Form.
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Fig. 2. Microscopic images of the surface of ODF loaded by paracetamol at the concentration of (a) 50% w/w and (b) 70% w/w and ketoprofen at the concentration of (c) 25% w/w and
(d) 50% w/w.
Hence, it can be assumed that NaPMM⁠2 allows designing ODF con-
taining 125mg paracetamol on a surface of about 6cm⁠2, maintaining ac-
ceptable tensile and biopharmaceutical properties.
ODF loaded with 25% w/w ketoprofen were transparent with a
smooth surface similarly to the placebo formulation suggesting the abil-
ity of NaPMM⁠2 to solubilize ketoprofen (Fig. 2c). Increasing the drug
content to 50% w/w, brittle films with a cracked surface were obtained
(Fig. 2d). The differences in morphology were consistent with thermal
data, since in DSC traces of ketoprofen loaded films, no events at about
96°C attributed to drug melting were evident.
The addition of a weak acidic drug, i.e. ketoprofen (pK⁠a=4.45), pre-
vented the disintegration of the ODF which swelled both in water and
artificial saliva (Form. 8 and 10 in Table 2) suggesting a partial pro-
tonation of NAPMM⁠2. Indeed, in the case of water the disaggregation
medium pH significantly dropped from 7.6 to 4.4. The lack of disin-
tegration influenced the drug dissolution only in the case of the film
loaded with the lowest drug amount (Form. 8), using artificial saliva as
dissolution medium. In this case the t⁠80 increased to about 10min (Table
2).
To verify the protonation of NaPMM⁠2, ATR-FTIR spectra of keto-
profen loaded formulations were compared to that of the placebo film
and HPMM⁠2. The attention was focused in the region from 1800 to
1300cm⁠−1 where the anti-symmetrical and symmetrical vibrations of
the carboxylate groups on NaPMM⁠2 are detected at 1560cm⁠−1 and be-
tween 1400 and 1300cm⁠−1, respectively. In case of the loaded ODF, the
intensity of both bands underwent a significant depression with respect
to the placebo film (Fig. 3). The ratio between the intensity of the C=O
of the ester group at about 1730cm⁠−1 and anti-symmetrical vibration of
the COO⁠− at about 1555cm⁠−1 increased as a function of the drug con-
tent confirming the re-protonation of methacrylate groups.
The lack of disintegration in presence of the acidic ketoprofen was
overcome by adding Span®80 and Tween®80 at 5% w/w. As an exam-
ple, in the case of 25% w/w ketoprofen-loaded ODF (Form. 9, Table 2),
the presence of the surfactants allowed to satisfy the disintegration test
without compromising the film mechanical properties (Table 2).
Fig. 3. ATR-FTIR spectra of HPMM⁠2 (black line), placebo ODF (blue line) and film loaded
by 50% w/w ketoprofen (red line). (For interpretation of the references to color in this
figure legend, the reader is referred to the web version of this article.)
4. Conclusions
All the presented data, discussed in the framework of the informa-
tion available on NaPMM⁠2, underlined the versatility of such mater-
ial that can be easily obtained by a simple salification of poly(methyl
methacrylate)s that are safe excipients already included in the main
pharmacopeia monographs. Indeed, the surface, mechanical and dis-
solution properties of NaPMM⁠2 can be modulated by adding a biva-
lent inorganic salt (Cilurzo et al., 2005) or a plasticizer. In the former
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forms. In the latter case, their film-forming properties can be exploited
to design pressure-sensitive adhesive suitable for medicated plasters
(plasticizer amount higher than 40% w/w) or, as demonstrated in this
work, ODF (PEG400 content lower than 30% w/w) with improved me-
chanical properties with respect to several polysaccharides already pro-
posed to formulate these dosage forms. Indeed, all ODF showed satisfac-
tory ductility, flexibility and resistance to elongation for the production,
packaging and handling procedures. Last but not least, the drug loading
up to 70% w/w of film weight appears to be the largest value described
in literature.
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